Cefuroxime-d3
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cefuroxime-d3
Description :
Cefuroxime-d3 is deuterium labeled Cefuroxime (sodium) . Cefuroxime sodium is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime sodium has a broad spectrum activity against Gram-positive and Gram-negative bacteria[1].UNSPSC :
12352005Hazard Statement :
H302-H315-H319-H335Target :
Antibiotic; Bacterial; Isotope-Labeled CompoundsType :
Isotope-Labeled CompoundsRelated Pathways :
Anti-infection; OthersApplications :
COVID-19-immunoregulationField of Research :
InfectionSolubility :
10 mM in DMSOSmiles :
OC(C1=C(COC(N)=O)CS[C@@]([C@@H]2NC(/C(C3=CC=CO3)=N\OC([2H])([2H])[2H])=O)([H])N1C2=O)=OMolecular Formula :
C16H13D3N4O8SMolecular Weight :
427.40Precautions :
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Callaghan, et al. Cefuroxime sodium, a New Cephalosporin Antibiotic: Activity in Vitro. Antimicrob Agents Chemother. 1976 Mar;9 (3) :511-9.|[3]D M Ryan, et al. Cefuroxime sodium, a New Cephalosporin Antibiotic: Activity in Vivo. Antimicrob Agents Chemother. 1976 Mar;9 (3) :520-5.Shipping Conditions :
Room temperatureScientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedIsoform :
β-lactamCAS Number :
[1803240-98-3]

